To test the feasibility of this assay, we used a classic target drug, namely, single-target imatinib, to establish the probe staining assay combined with IF of its target CD117 and other methods and evaluate the reliability of the proposed method on gastrointestinal stromal tumor (GIST) (Joensuu et al., 2013). This evidence concerns the gene KIT and gastrointestinal stromal tumor.